AR002246A1 - Nuevas sales por adicion de acidos de cefem procedimientos para su preparacion, el empleo de las mismas para la preparacion de medicamentos, y elprocedimiento para la preparacion de dicho medicamento. - Google Patents

Nuevas sales por adicion de acidos de cefem procedimientos para su preparacion, el empleo de las mismas para la preparacion de medicamentos, y elprocedimiento para la preparacion de dicho medicamento.

Info

Publication number
AR002246A1
AR002246A1 ARP950100095A AR10009595A AR002246A1 AR 002246 A1 AR002246 A1 AR 002246A1 AR P950100095 A ARP950100095 A AR P950100095A AR 10009595 A AR10009595 A AR 10009595A AR 002246 A1 AR002246 A1 AR 002246A1
Authority
AR
Argentina
Prior art keywords
preparation
procedures
addition
acids
cefem
Prior art date
Application number
ARP950100095A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of AR002246A1 publication Critical patent/AR002246A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48Methylene radicals, substituted by hetero rings
    • C07D501/56Methylene radicals, substituted by hetero rings with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Nuevas sales por adición de ácidos de cefem cristalinas y procedimientos para su preparación. Compuestos de la fórmula (I), en donde n es igual a 1 ó 2y m es 0,4-2,6 y en donde X significa el anión de un ácido carboxílico, presentan una actividad antibacteriana.
ARP950100095A 1994-11-10 1995-11-08 Nuevas sales por adicion de acidos de cefem procedimientos para su preparacion, el empleo de las mismas para la preparacion de medicamentos, y elprocedimiento para la preparacion de dicho medicamento. AR002246A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4440141A DE4440141A1 (de) 1994-11-10 1994-11-10 Neue kristalline Cephem-Säureadditionssalze und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
AR002246A1 true AR002246A1 (es) 1998-03-11

Family

ID=6532953

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP950100095A AR002246A1 (es) 1994-11-10 1995-11-08 Nuevas sales por adicion de acidos de cefem procedimientos para su preparacion, el empleo de las mismas para la preparacion de medicamentos, y elprocedimiento para la preparacion de dicho medicamento.

Country Status (28)

Country Link
US (1) US5747484A (es)
EP (1) EP0711774B1 (es)
JP (1) JP3920939B2 (es)
KR (1) KR100449191B1 (es)
CN (1) CN1066452C (es)
AR (1) AR002246A1 (es)
AT (1) ATE213248T1 (es)
AU (1) AU707730B2 (es)
BR (1) BR9505132A (es)
CA (1) CA2162530C (es)
CZ (1) CZ290936B6 (es)
DE (2) DE4440141A1 (es)
DK (1) DK0711774T3 (es)
ES (1) ES2172549T3 (es)
FI (1) FI120263B (es)
HU (1) HU219475B (es)
IL (1) IL115914A (es)
MA (1) MA23709A1 (es)
NO (1) NO311891B1 (es)
NZ (1) NZ280424A (es)
OA (1) OA10242A (es)
PL (1) PL182806B1 (es)
PT (1) PT711774E (es)
RU (1) RU2161619C2 (es)
SK (1) SK282545B6 (es)
TR (1) TR199501392A2 (es)
TW (1) TW422847B (es)
ZA (1) ZA959510B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0980350A4 (en) * 1997-04-29 2003-01-02 Univ New Mexico ASYMMETRICAL SYNTHESIS OF BENZOXAZINOES ON NEW INTERMEDIATE PRODUCTS
MXPA05004219A (es) * 2002-10-25 2005-06-08 Akzo Nobel Nv Composicion farmaceutica de liberacion prolongada.
EP1945223B1 (en) * 2005-10-29 2010-07-07 Intervet International BV Cefquinome compositions and methods of their use
AR077320A1 (es) * 2009-07-20 2011-08-17 Intervet Int Bv Metodo para la preparacion de particulas de cefquinoma y formulaciones farmaceuticas que las comprenden.
WO2013036783A2 (en) 2011-09-09 2013-03-14 Cubist Pharmaceuticals, Inc. Methods for treating intrapulmonary infections
WO2013049294A1 (en) * 2011-09-29 2013-04-04 Alere San Diego, Inc. 2-hydroxyhippuric acid analogs, and methods for their synthesis and use
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3248281A1 (de) * 1982-12-28 1984-06-28 Hoechst Ag, 6230 Frankfurt Kristalisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung
DE3316797A1 (de) * 1983-05-07 1984-11-08 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von cephemverbindungen
DE3706020A1 (de) * 1987-02-25 1988-09-08 Hoechst Ag Kristallisierte cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
HUT74163A (en) 1996-11-28
TW422847B (en) 2001-02-21
NZ280424A (en) 1997-06-24
NO954511D0 (no) 1995-11-09
EP0711774A1 (de) 1996-05-15
RU2161619C2 (ru) 2001-01-10
NO311891B1 (no) 2002-02-11
JPH08208662A (ja) 1996-08-13
ES2172549T3 (es) 2002-10-01
CA2162530C (en) 2007-07-31
KR100449191B1 (ko) 2006-01-12
SK139795A3 (en) 1996-06-05
CN1066452C (zh) 2001-05-30
ATE213248T1 (de) 2002-02-15
CN1129220A (zh) 1996-08-21
CZ293395A3 (en) 1996-05-15
KR960017670A (ko) 1996-06-17
JP3920939B2 (ja) 2007-05-30
IL115914A0 (en) 1996-01-31
AU707730B2 (en) 1999-07-15
SK282545B6 (sk) 2002-10-08
FI955382A (fi) 1996-05-11
AU3772895A (en) 1996-05-16
PL182806B1 (pl) 2002-03-29
PT711774E (pt) 2002-07-31
TR199501392A2 (tr) 1996-07-21
IL115914A (en) 2002-08-14
OA10242A (fr) 1997-09-19
CA2162530A1 (en) 1996-05-11
BR9505132A (pt) 1997-09-09
HU219475B (hu) 2001-04-28
CZ290936B6 (cs) 2002-11-13
DE59510048D1 (de) 2002-03-21
EP0711774B1 (de) 2002-02-13
MA23709A1 (fr) 1996-07-01
PL311326A1 (en) 1996-05-13
DK0711774T3 (da) 2002-04-22
DE4440141A1 (de) 1996-05-15
US5747484A (en) 1998-05-05
FI120263B (fi) 2009-08-31
FI955382A0 (fi) 1995-11-08
HU9503213D0 (en) 1996-01-29
ZA959510B (en) 1996-05-28
NO954511L (no) 1996-05-13

Similar Documents

Publication Publication Date Title
ES2102132T3 (es) Amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
AR002246A1 (es) Nuevas sales por adicion de acidos de cefem procedimientos para su preparacion, el empleo de las mismas para la preparacion de medicamentos, y elprocedimiento para la preparacion de dicho medicamento.
ES2063093T3 (es) Composiciones orales.
PT95826A (pt) Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico
ES2054995T3 (es) Nuevos derivados del acido benzoico y acido fenilacetico, su obtencion y empleo como medicamentos.
MX9200063A (es) Derivados de acidos tetrahidrofolicos y procedimiento para su preparacion.
SE8400332L (sv) Forening for anvendning som mellanprodukt vid framstellning av lekemedel
MX9204110A (es) Derivados del acido quinolonacarboxilico y procedimiento para su preparacion.
DE3665711D1 (de) Novel guanidinomethylbenzoic acid derivatives
PT90163A (pt) Processo para a preparacao de derivados da cefalosporina com actividade antibacteriana
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
PT82512A (fr) Procede de preparation de derives de quinolylglycinamides ayant activite psychotrope et de compositions pharmaceutiques les contenant
CO4290351A1 (es) Proceso
ES2079349T3 (es) Sales por adicion de acidos de cefem cristalizadas y procedimiento para su preparacion.
HUT45081A (en) Process for producing amino acid derivatives and pharmaceuticals comprising these compounds as active ingredient
ES2082882T3 (es) Procedimiento para la fabricacion de derivados de acidos-3-amino-2-(het)aroil-acrilicos.
ES2045653T3 (es) Sales cristalinas por adicion de acidos de cefem y procedimiento para su preparacion.
ES2135500T3 (es) Producto farmaceutico para el tratamiento de trastornos de la piel.
DE69224497T2 (de) Faktor C2a des Antibiotikums CE 2270
FI893677A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6-fluori-3,5-dihydroksikarboksyylihappojen ja niiden johdannaisten valmistamiseksi
ATE140922T1 (de) 3- oder 4-glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches mittel
DE3684186D1 (de) Verwendung von pharmaceutischen zusammensetzungen fuer die herstellung von arzneimitteln fuer die behandlung psychiatrischer stoerungen.
BR9912200A (pt) Mumbaistatina, processo para sua produção e seuuso como produto farmacêutico
ATE163294T1 (de) Die antibiotika ge 37468 a, b und c
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные